Nuramed

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nuramed

Quick Facts

Property Description
Active ingredient Pregabalin
Form Oral capsule, oral tablet, oral solution
Pharmacological class Anticonvulsant, Gabapentinoid
General therapeutic purpose Stabilization of overactive nerve signaling
Origin Synthetic (chemically synthesized)

What Type of Medicine is Nuramed (Pregabalin)?

Nuramed is the trade name for the prescription-only synthetic compound, Pregabalin, which is classified pharmacologically as an anticonvulsant and a gabapentinoid. The active substance, Pregabalin, is structurally related to the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). As a single active ingredient product, Nuramed relies solely on Pregabalin, which is created through a chemical synthesis process, establishing its purely synthetic origin. Pregabalin is clinically recognized for its high affinity for a specific calcium channel subunit, setting it apart from classic antiepileptic agents.

The General Purpose and Function of Nuramed

The general purpose of Nuramed is to promote neuronal stabilization by regulating excessive signaling within the nervous system. Pregabalin achieves this by binding to the alpha2delta subunit of presynaptic voltage-gated calcium channels, which in turn modulates the release of various excitatory neurotransmitters. This mechanism helps to quiet hypersensitized nerve pathways and reduce abnormal electrical impulses. For instance, the drug's action addresses the underlying nerve overactivity often associated with chronic nerve pain. The ultimate goal is to dampen exaggerated signaling to restore a more balanced nervous system function.

Available Forms of Nuramed

Nuramed is formulated exclusively for the oral route of administration and is supplied in several distinct pharmaceutical preparations. These preparations typically include the standard oral capsule, which offers immediate release, a specialized oral extended-release tablet designed for slower, sustained delivery of the active ingredient, and an oral solution (liquid). The provision of both immediate-release and extended-release forms, the latter being a differentiating factor for sustained daily use, ensures that the drug's pharmacokinetic profile can be tailored to meet the specific requirements for nerve stabilization.

Regulatory References

  1. MedlinePlus
  2. NCBI StatPearls on Pregabalin Mechanism

What side effects are possible with Nuramed?

Possible Side Effects

Nuramed, a medication containing pregabalin, is generally associated with mild to moderate side effects. These often decrease as the body adjusts to the treatment.

Common Side Effects

Side effects that occur frequently (in more than 1 in 10 people) typically include dizziness and drowsiness (sleepiness). Other common effects include:

System Side Effect
General Weight gain, dry mouth, blurred vision, swelling of the hands/feet (peripheral edema)
Nervous System Difficulty concentrating/attention, lack of coordination (ataxia), euphoria (feeling high), confusion, memory impairment, tremor, headache
Gastrointestinal Constipation, nausea, vomiting

Serious Warnings and Precautions

  • Hypersensitivity: Seek immediate medical attention if you experience signs of a severe allergic reaction (angioedema), such as swelling of the face, lips, tongue, or throat, or difficulty breathing.
  • Suicidal Thoughts: This class of medicine may increase the risk of suicidal thoughts or behavior. Report any changes in mood or behavior to your doctor promptly.
  • Dependence and Withdrawal: Nuramed has the potential for dependence, especially with prolonged use or misuse. Do not stop taking Nuramed abruptly; sudden cessation can lead to withdrawal symptoms like anxiety, insomnia, headache, and nausea. The dose should be reduced gradually under a doctor's supervision.
  • Pre-existing Conditions: Use with caution and discuss with your doctor if you have a history of kidney disease, heart problems (like heart failure), drug/alcohol abuse, or diabetes.
  • Pregnancy and Breastfeeding: Nuramed is generally not recommended during pregnancy or breastfeeding unless deemed essential by a physician, as the risks to the fetus or infant are not fully established.
  • Driving: Due to the risk of dizziness and blurred vision, do not drive or operate machinery until you know how the medication affects you.

Overdose and Emergency Response

Pregabalin overdose is documented in official regulatory sources with a spectrum of clinical manifestations, primarily affecting the Central Nervous System.

Documented Overdose Manifestations

The most commonly reported signs associated with overdose include somnolence (extreme sleepiness), a confusional state, and agitation. Other clinical presentations noted in regulatory documentation are restlessness, reduced consciousness, and speech disturbances (slurred speech).

Severe Risks and Emergency Actions

The U.S. Food and Drug Administration (FDA) has warned that serious and life-threatening complications, including seizures, coma, and death, may occur, especially due to respiratory depression (slowed, shallow, or difficult breathing). This risk is increased when pregabalin is co-ingested with other Central Nervous System (CNS) depressants, such as opioids.

Immediate emergency medical help must be sought if unresponsiveness, seizures, or any signs of severe respiratory problems occur.

Supportive Management

There is no specific antidote known for pregabalin overdose. Treatment is focused on general supportive care of the patient, which includes monitoring vital signs and clinical status. Procedures such as gastric lavage may be considered, and the drug is removable from the body using standard hemodialysis procedures.

Population-Specific Notes

Regulatory summaries note that patients with renal impairment are at an increased risk of severe toxicity due to the drug’s primary elimination route through the kidneys.

Therapeutic Uses of Nuramed

What Nuramed Treats: Main Uses and Benefits

Nuramed (Pregabalin) is commonly used across domains where additional symptomatic support is needed for conditions involving symptoms of increased neurological or muscular activity. The medication is generally applied in scenarios where symptoms create noticeable functional strain, provides supportive relief when symptoms interfere with routine activities.

The medication is commonly used to help manage symptoms of chronic nerve pain, specifically diabetic peripheral neuropathy and postherpetic neuralgia (pain after shingles), and symptoms of fibromyalgia. It is also applied as an adjunctive therapy for partial-onset seizures and in the management of Generalized Anxiety Disorder (GAD).

“This supportive relief may help patients cope more steadily with symptom fluctuations and supports patients during episodes of heightened discomfort.”

By addressing these symptom clusters, the benefit contributes to easing the overall symptom load, which helps improve day-to-day comfort during symptomatic periods.


Quick Fact: Therapeutic Focus: Symptom Management Property Description
Primary Symptoms Burning, shooting nerve pain; pervasive anxiety; seizure activity
Typical Context Chronic conditions and adjunctive therapy for refractory symptoms
Patient Benefit Contributes to easing the overall symptom load and supports stability

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Nuramed (Pregabalin)

Eligibility Scope

Category Eligibility Statements (Based on Official Regulatory Documents)
Populations for whom use is allowed Adults (18 years and older) are approved for all major indications. Use is permitted for patients without a known history of hypersensitivity to pregabalin.
Populations for whom use is contraindicated Patients with known hypersensitivity to the active substance, pregabalin, or any of the product’s excipients, must not use the medicine.
Age-related eligibility rules Use is generally not recommended in children and adolescents under 18 years for non-seizure indications. Older adults (ge 65 years) may require a dose review if reduced kidney function is present.
Condition-specific restrictions Patients with renal impairment are eligible only after a mandated dose adjustment based on their kidney function. No routine dose adjustment is needed for hepatic impairment.
Pregnancy and lactation eligibility status Use is not recommended during pregnancy; women of childbearing potential are required to use effective contraception during treatment. Use is also not recommended during lactation.

Eligibility Classification

The official eligibility profile establishes an absolute contraindication for hypersensitivity. Use is classified as conditional for patients with renal impairment and those with a history of angioedema or substance abuse. The medication is officially not recommended for most pediatric groups, pregnant women, and breastfeeding mothers.

What should I know about interactions with other medicines?

Nuramed’s official regulatory profile is primarily defined by a minimal risk of pharmacokinetic (PK) interactions. The drug is eliminated predominantly unchanged and undergoes negligible metabolism, meaning it is not expected to inhibit or induce the metabolism of other medicinal products. Clinical studies confirm there is no clinically relevant PK interaction with co-administered medicines such as phenytoin, carbamazepine, valproic acid, lamotrigine, or oxycodone.

The main documented interactions are pharmacodynamic (PD) in nature. Co-administration with central nervous system (CNS) depressants, including opioids and benzodiazepines, potentiates effects like somnolence and dizziness, and carries an increased risk of severe respiratory depression. This respiratory risk is heightened in the elderly and patients with renal impairment. Furthermore, the co-consumption of alcohol is documented to potentiate the CNS depressant effects of the drug.

An additive risk exists with thiazolidinedione antidiabetic agents, which may increase the occurrence of peripheral edema and weight gain. This may necessitate the adjustment of hypoglycaemic medicinal products in diabetic patients. Nuramed may be administered with or without food, as this does not significantly affect its total absorption.

Mechanism of Action

How Nuramed Modulates Nerve Signal Release

Nuramed functions at the molecular level through binding to the accessory alpha-2-delta (alpha2delta) subunit of presynaptic nerve cell channels, which are necessary for the calcium-dependent release of chemical signals. This targeted interaction interferes with the channel's trafficking to the nerve surface, reducing calcium ion influx upon depolarization and thereby limiting the release of excitatory neurotransmitters into the communication space (synapse).

Modulation of Central Neuronal Activity

The result of decreased excitatory signal release is a localized dampening of electrical signals across specific nerve circuits, particularly those in the spinal cord and brain that exhibit heightened neuronal activity. By modifying these fundamental molecular steps, this action results in the suppression of centralized overactivity and modulates the affected pathways, which contributes to the resulting physiological changes.

Dosage and Administration Information

How Nuramed is Used: Official Administration Guidelines

Nuramed (Pregabalin) is administered exclusively by the oral route, supplied as immediate-release capsules, an oral solution, and extended-release tablets. The overall usage pattern is defined by a necessary dose-adjustment protocol, a gradual introduction period, and specific rules for administration timing.

Dosing Schedule and Frequency

For most adults, the immediate-release formulation typically begins at a starting dose of 150 mg per day, which is taken in two (BID) or three (TID) divided doses. The dosage is gradually increased, or titrated, over a minimum period of at least one week to reach the general maintenance range of 150 mg to 600 mg per day. The maximum recommended daily amount for most indications is 600 mg. In contrast, the extended-release tablet is administered once daily (QD), with maintenance doses up to 330 mg or 660 mg once daily depending on the indication.


Administration Context and Adjustments

Immediate-release capsules may be taken with or without food. However, the extended-release tablets must be swallowed whole and are specified to be taken after an evening meal. The dosage plan is not static; it is mandatory that the total daily amount be adjusted for individuals with reduced kidney function, as defined by their creatinine clearance. Finally, when treatment with Nuramed is concluded, it must be gradually tapered over a minimum period of at least one week to complete the full usage protocol.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Nuramed (Pregabalin)


Evidence for use in Chronic Nerve Pain (Neuropathic Pain)

For conditions like painful Diabetic Peripheral Neuropathy (DPN) and Postherpetic Neuralgia (PHN), the evidence primarily comes from numerous short-term, randomized, double-blind, placebo-controlled trials (RCTs). These RCTs are foundational to research exploring how symptoms change over time. Primary outcomes measured were patient-reported outcomes describing perceived discomfort, focusing mainly on the change in mean daily pain scores and scores for sleep interference.

Across these core trials, research describes patterns related to short-term outcomes that were measured, documenting how pain intensity and sleep disturbance evolved in the observed populations. However, long-term outcomes remain insufficiently characterized. The follow-up durations were limited in the core efficacy trials, meaning that consistent long-term outcomes are not fully established over many years.


Evidence for use in Generalized Anxiety Disorder (GAD)

Research exploring this compound in GAD has utilized short-term randomized controlled trials applied in research contexts involving fluctuating or unstable symptoms. Researchers used standardized instruments, such as the Hamilton Anxiety Rating Scale (HAM-A), to measure outcomes related to systemic or functional imbalance, specifically looking at changes in psychic and somatic anxiety symptoms.

Findings from these studies describe patterns observed in the trials, focusing on how anxiety severity scores changed over short treatment intervals (typically 4 to 8 weeks). The certainty remains low regarding consistent outcomes, as most core efficacy data are derived from these short treatment periods. Long-term outcomes remain insufficiently characterized.


Evidence for use in Fibromyalgia and Partial-Onset Seizures

For fibromyalgia, short-term RCTs were used to monitor outcomes reflecting daily functioning, including changes in pain scores and function assessed by tools like the Fibromyalgia Impact Questionnaire (FIQ). Data are still emerging regarding consistency for this indication. In the context of partial-onset seizures, the research examined the compound as an add-on therapy for adolescents and adults, monitoring the percentage change in seizure frequency over a defined 12-week period. Evidence for using the compound alone (monotherapy) is less established within the core regulatory research base.

Frequently Asked Questions (FAQ)

Common questions about Nuramed (FAQ)


Q: How does Nuramed work to stop nerve pain?

A: Nuramed is formally classified as an anticonvulsant. Official product information states that its action involves binding to a specific site on the nerve cells, called the alpha2delta subunit. This action helps to modulate the release of several excitatory chemical signals (neurotransmitters), which is thought to reduce the overactivity of nerve pathways associated with pain.

Q: Is Nuramed considered a type of painkiller?

A: Nuramed is formally classified as an anticonvulsant or gabapentinoid. While it is approved for the treatment of certain types of pain, specifically nerve pain (neuropathic pain), its mechanism of action is different from traditional over-the-counter painkillers like acetaminophen or ibuprofen.

Q: Is Nuramed the same as Lyrica, or are they different drugs?

A: Nuramed and Lyrica are both brand names for the exact same active prescription ingredient, pregabalin. Both products contain the identical medicine and function in the same way.

Q: Is it true that Nuramed can also be used for anxiety disorders?

A: Yes, official regulatory documents indicate that Nuramed (pregabalin) is approved and indicated for the treatment of Generalized Anxiety Disorder (GAD) in adults, in addition to its uses for nerve pain and seizures.

Q: How long does it typically take for Nuramed to start providing noticeable relief?

A: Clinical studies often measure patient outcomes over short treatment intervals, typically 4 to 8 weeks, suggesting that the full effect is not immediate. Regulatory data indicates that the timeframe for experiencing noticeable relief can vary widely between individuals and conditions.

Q: How long can a person safely stay on Nuramed treatment?

A: Regulatory documents state that core clinical trials were often short-term, meaning that consistent long-term outcomes over many years are not fully characterized. Official guidance emphasizes that the decision regarding long-term use requires ongoing medical assessment to weigh the drug's benefits against potential risks.

Q: Is Nuramed a habit-forming or addictive medicine?

A: According to official regulatory profiles, Nuramed has the potential for dependence and misuse. For this reason, it is generally classified as a Controlled Substance in many regions, such as Schedule V in the US, and requires careful monitoring.

Q: What happens if I stop taking Nuramed suddenly?

A: Official warnings advise against stopping the medication abruptly. Sudden or rapid discontinuation may cause withdrawal symptoms, which can include anxiety, insomnia, headaches, nausea, and may potentially increase the risk for seizures. Official instructions mandate that the dose must be reduced gradually (tapered) under medical supervision.

Q: Is weight gain a common side effect of Nuramed, and how is it managed?

A: Weight gain is listed as a common side effect. For patients with diabetes taking certain antidiabetic medicines, the risk of weight gain and associated fluid retention is noted in the label, which may necessitate an adjustment of their other hypoglycaemic medicinal products.

Q: Can Nuramed cause blurred vision or other eye problems?

A: Blurred vision is a common side effect. Less common side effects reported in official documents include visual disturbance, double vision (diplopia), reduced visual acuity, and swelling of the eye. Official warnings note that these effects are often transient and may resolve upon discontinuation of the medication, though this varies by patient.

Q: Does Nuramed interact with common over-the-counter pain relievers?

A: Regulatory documents state there are no clinically relevant pharmacokinetic (PK) interactions with several major antiepileptic drugs. However, there is no explicit statement in the product information confirming the absence of interaction with all common over-the-counter pain relievers.

Q: Is it safe to take Nuramed with medicines for high blood pressure (ACE inhibitors)?

A: Official information indicates that Nuramed is mostly eliminated from the body unchanged and undergoes negligible metabolism. This suggests it is not expected to cause pharmacokinetic interactions (interfere with how the body processes the other drug) with most co-administered medicines, including many blood pressure medications.

Q: Are there any known interactions between Nuramed and oral contraceptive pills?

A: According to the official product information, Nuramed is not expected to interfere with the metabolism of other medicinal products. This means it is not expected to reduce the effectiveness of oral contraceptive pills.

Q: Is Nuramed safe for use in elderly patients, and what are the concerns?

A: Nuramed can be used in the elderly (ge 65 years), but they may require a dose reduction if there is decreased kidney function. Official warnings also note that elderly patients have an increased risk of accidental injury (fall) due to the common side effects of dizziness and drowsiness.

Q: What is the risk of taking Nuramed if I have a history of heart problems or heart failure?

A: Official warnings state that the medicine is to be used with caution in patient populations who have a history of congestive heart failure. This is because the drug is associated with peripheral edema (swelling) and weight gain, which can potentially worsen symptoms of heart failure in susceptible patients.

Q: Does Nuramed affect blood sugar levels, especially for people with diabetes?

A: Nuramed does not directly cause changes to blood sugar itself. However, because it can cause weight gain and fluid retention, especially when combined with certain diabetes medicines, this may necessitate a review or adjustment of other diabetes medications.

Q: Why do some people experience tingling or pins and needles when stopping Nuramed?

A: The sensation of pins and needles (paresthesia) is listed as an uncommon adverse reaction during regular treatment in official documents. However, it is not explicitly listed as one of the established withdrawal symptoms caused by stopping the medication.

Q: Is Nuramed considered a controlled substance in many countries?

A: Yes, due to its potential for dependence and misuse, Nuramed (pregabalin) is classified as a controlled substance in many major jurisdictions. For example, it is a Schedule V Controlled Substance in the US and a Class C/Schedule 3 drug in the UK.

Q: Can Nuramed affect fertility in men or women?

A: Official regulatory documents indicate there are no clinical data on the effects of the drug on female fertility. For men, studies showed no effect on sperm motility (the ability of sperm to move) after 3 months of treatment at higher doses.

Q: Is it normal to feel a lack of coordination (clumsiness) while on Nuramed?

A: Yes, official regulatory documents list a lack of coordination (ataxia) as a common side effect associated with Nuramed. As with many common side effects, this symptom may lessen as the body adjusts to the medication.

Q: Are there different forms or strengths of Nuramed available, like 75mg or 150mg?

A: Yes, Nuramed (pregabalin) is available in several dosage forms, including both oral capsules and tablets. Official product information lists a wide range of available capsule and tablet strengths, which are used to help doctors gradually adjust the dosage.

Q: How long do the effects of a single dose of Nuramed usually last?

A: The immediate-release forms of Nuramed are typically prescribed to be taken two (BID) or three (TID) times a day to maintain a stable amount of the medicine in the body. This indicates that the effects of a single dose are expected to last for approximately 8 to 12 hours.

Q: What is the typical starting time frame to see full benefits for nerve pain versus epilepsy?

A: Clinical trials for both nerve pain and epilepsy measured outcomes over several weeks to capture the drug's full effect, typically around 8 to 12 weeks. This timeframe is generally needed after the dose has been gradually adjusted to a stable level.

How should Nuramed be stored and disposed of?

The official regulatory documents define mandatory requirements for storing and disposing of Nuramed (Pregabalin) to ensure the product's integrity and public safety.

Storage Requirements

Condition Official Regulatory Statement
Temperature & Protection Store at controlled room temperature, typically below 30 C, protected from light and moisture.
Packaging Keep the medication in the original container and ensure the container is tightly closed.
Child Safety Keep out of the sight and reach of children; some regulatory guidance specifies storing it locked up due to its classification.

Disposal Requirements

Expired or unused Nuramed must not be discarded with household waste or flushed down the wastewater system. Instead, the product must be disposed of in accordance with local requirements for unused medicine, often involving drug take-back programs or designated collection sites.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nuramed found in:

A-Z Index: